01 GLYCOPYRROLATE (4)
01 EXELA PHARMA (4)
01 SOLUTION;INTRAMUSCULAR, INTRAVENOUS (4)
01 0.2MG/ML (0.2MG/ML) (1)
02 0.4MG/2ML (0.2MG/ML) (1)
03 0.6MG/3ML (0.2MG/ML) (1)
04 1MG/5ML (0.2MG/ML) (1)
01 USA (4)
19
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GLYCOPYRROLATE, with a corresponding application number 210997 and regulatory information .
proudly manufactured in the
approval since 2018-07-11
Exela Pharma Sciences, LLC.'s GLYRX-PF SOLUTION;INTRAMUSCULAR, INTRAVENOUS, medication with 0.2MG/ML (0.2MG/ML) of GLYCOPYRROLATE.
18
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GLYCOPYRROLATE, with a corresponding application number 210997 and regulatory information .
proudly manufactured in the
approval since 2020-12-14
Exela Pharma Sciences, LLC.'s GLYRX-PF SOLUTION;INTRAMUSCULAR, INTRAVENOUS, medication with 0.6MG/3ML (0.2MG/ML) of GLYCOPYRROLATE.
17
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GLYCOPYRROLATE, with a corresponding application number 210997 and regulatory information .
proudly manufactured in the
approval since 2018-07-11
Exela Pharma Sciences, LLC.'s GLYRX-PF SOLUTION;INTRAMUSCULAR, INTRAVENOUS, medication with 0.4MG/2ML (0.2MG/ML) of GLYCOPYRROLATE.
16
Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GLYCOPYRROLATE, with a corresponding application number 210997 and regulatory information .
proudly manufactured in the
approval since 2020-04-09
Exela Pharma Sciences, LLC.'s GLYRX-PF SOLUTION;INTRAMUSCULAR, INTRAVENOUS, medication with 1MG/5ML (0.2MG/ML) of GLYCOPYRROLATE.